Alfresa Group
at a Glance

Alfresa Group’s overview for your quick understanding

The name “Alfresa” combines
the English word “all” with
the Esperanto word “fresa,” which means “fresh.”

The Alfresa Group
is a corporate group
that supports the pharmaceutical supply chains in Japan,
which are indispensable for maintaining people's health and life.

Through the Ethical Pharmaceuticals Wholesaling Business, the Self-medication Products
Wholesaling Business, the Manufacturing Business, and the Medical-related Business,
the Alfresa Group works as one to support the pharmaceutical supply chains that
are part of Japan’s social infrastructure, and strives to meet the full range of medical needs.

Group Companies

  • Ethical Pharmaceuticals Wholesaling Business
  • Self-Medication Products Wholesaling Business
  • Manufacturing Business
  • Medical-Related Business
  • Information System Business for the Alfresa Group

QINGDAO NESCO MEDICAL CO., LTD. Alfresa Fine Chemical Corporation Tohoku Alfresa Corporation Meisho Co., Ltd. TS Alfresa Corporation Alfresa Shinohara Chemicals Corporation Shikoku Alfresa Corporation Alfresa Pharma Corporation Alfresa Corporation Alfresa Medical Service Corporation A・L Plus Co., LTD. Alfresa Healthcare Corporation APOCREAT Corporation Alfresa System Corporation RYUYAKU CO., LTD.

Providing products and services in every health-related field Becoming a Healthcare Consortium

We aim to become a Healthcare Consortium that provides products and services in every health-related field. To that end, we strive to be a corporate group that is a close partner in people's life journeys, capable of displaying its manufacturing, wholesaling, distribution, family pharmacy, and information provision functions to the fullest.

Alfresa Group’s Data

Group Management Results

  • Operating Income Margin1.12%

  • Profit Margin Attribute to
    Owners of the Parent

  • Total Assets1,339.8billion yen

  • Owner’s Equity Ratio36.4%

  • Return on Equity5.4%

  • Earnings per Share127.42yen

Business Foundation

Shareholder Return

  • Dividend on Equity Ratio2.4%

  • Payout Ratio44.7%

  • Total Shareholder Return82.7%

●The figures shown are as of March, 2023.

* According to the latest edition of Pharmaceuticals Industry Rankings (Drugmagazine Co., Ltd.)

Alfresa Group’s Strength

  • Robust distribution system

    We are effectively positioning our distribution centers with high processing capabilities and building a distribution platform that meets the needs of customers such as hospitals, dispensing pharmacies, and drugstores through a nationwide network of branches and offices.

  • Relationships of trust with customers and suppliers

    We have established a position as the No. 1 ethical pharmaceuticals wholesaler in net sales by building up wide-ranging transactions with pharmaceutical and medical equipment manufacturers, and strong relationships of trust with customers. We also aim to create new value by serving as a connection between medical care, nursing care, local government, and others.

  • Human resources that support high productivity

    The entire Alfresa Group is keen to review routine work and utilize new technologies. By increasing efficiency in existing work processes, we aim to improve productivity by reallocating management resources to new endeavors.

  • Group synergies from broad business domains

    We have built a supply chain for pharmaceuticals and other products that spans from manufacturing to wholesale and final delivery of medicine to patients at dispensing pharmacies. By utilizing this supply chain, we also operate a wide range of businesses, including the prevention of disease, as well as curing, diagnosis, and treatment procedures. We will maximize synergies between each business segment.

What We Value

Our valuable people

The Alfresa Group
considers its valuable people
to be the true driver for sustainable growth into the future

To create and deliver a fresh life for all, we are working
to develop talent who flexibly respond to all medical needs,
have willingness to challenge and continue to grow.

Ability to adapt to changing environments

The ability to adapt quickly to new business opportunities and work environments, and to fully leverage unique capabilities, contributes to the results of the team.

Willingness to venture into uncharted areas

This is the most important requirement for creating new value and business under the management environment at any given time.

High ethical standards that earn trust

This is an important attribute for cultivating the sense of trust that is essential to be entrusted with life-related work.

Strong sense of mission for work that supports life

A high sense of mission is one of the values required of an employee involved in work that supports life.

Promote the Alfresa Group's Diversity Policy, established in 2020

  • Establish career paths that go beyond segments
  • Enhance recruitment activities
  • Enhance human resource development
  • Promote the success of women
  • Utilize junior and senior employees
  • Introduce systems that accommodate a variety of life stages